Allos Therapeutics Inc

CIK 1097264 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Allos Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Sep 26, 2017CT ORDER9999999997-17-008890
Sep 20, 2016CT ORDER9999999997-16-025882
Oct 9, 2012SC 13G/A0000891092-12-005856
Sep 17, 201215-12G0001193125-12-393879
Sep 6, 201230001181431-12-049055
Sep 6, 2012S-8 POS0001193125-12-382506
Sep 6, 2012S-8 POS0001193125-12-382519
Sep 6, 201230001181431-12-049054
Sep 6, 201240001181431-12-049057
Sep 6, 201230001181431-12-049056
Sep 6, 2012SC 13D/A0000899140-12-000536
Sep 6, 2012S-8 POS0001193125-12-382493
Sep 6, 2012S-8 POS0001193125-12-382512
Sep 6, 201240001140361-12-039646
Sep 5, 201240001127602-12-025784
Sep 5, 201240001127602-12-025794
Sep 5, 201240001127602-12-025797
Sep 5, 201240001127602-12-025790
Sep 5, 2012SC 14D9/A0001193125-12-381098
Sep 5, 201240001127602-12-025798
Sep 5, 201240001127602-12-025800
Sep 5, 2012SC TO-T/A0001193125-12-381079
Sep 5, 201225-NSE0001354457-12-000194
Sep 5, 20128-K0001193125-12-381132
Sep 5, 201240001127602-12-025787